Literature DB >> 17163802

Opioid maintenance: a comparative review of pharmacological strategies.

Jason M White1, Olga V Lopatko.   

Abstract

The use of opioids outside of medical practice is a significant health problem with important social and political implications. Although treatment of opioid dependence is traditionally focused on heroin users, there is increasing recognition that a large number of people become dependent through the use of prescription opioids. The necessity for long-term treatment has also been increasingly recognised. At present, there are several pharmacotherapies available for maintenance treatment, including drugs that are full agonists at the opioid receptor (e.g., methadone, slow-release oral morphine), a partial agonist (buprenorphine) and an opioid antagonist (naltrexone). This review examines the existing strategies, highlights problems associated with their use and discusses the opportunities for new treatment approaches, particularly the use of long-acting formulations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17163802     DOI: 10.1517/14656566.8.1.1

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  4 in total

1.  1-Substituted 4-(3-Hydroxyphenyl)piperazines Are Pure Opioid Receptor Antagonists.

Authors:  F Ivy Carroll; Juan Pablo Cueva; James B Thomas; S Wayne Mascarella; Scott P Runyon; Hernán A Navarro
Journal:  ACS Med Chem Lett       Date:  2010-10-14       Impact factor: 4.345

2.  Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence.

Authors:  Teresa R Gray; Riet Dams; Robin E Choo; Hendree E Jones; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2010-07-27       Impact factor: 2.395

Review 3.  Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.

Authors:  Richard B Rothman; Bruce E Blough; Michael H Baumann
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

4.  Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.

Authors:  Thilo Beck; Christian Haasen; Uwe Verthein; Stephan Walcher; Christoph Schuler; Markus Backmund; Christian Ruckes; Jens Reimer
Journal:  Addiction       Date:  2014-01-19       Impact factor: 6.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.